(Q51486830)

English

A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis.

scientific article published on 19 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

author name string

Gina M Michels

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Kelly F Walsh

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Kristina A Kryda

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Sean P Mahabir

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Rodney R Walters

5

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Jacquelien D Hoevers

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Olivier M Martinon

7

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

publication date

19 September 2016

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Veterinary Dermatology

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

27

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

6

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

505-e136

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF.

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Elimination mechanisms of therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Mechanisms of monoclonal antibody-drug interactions

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Immunogenicity of engineered antibodies

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

1 reference

https://api.crossref.org/works/10.1111%2FVDE.12364

21 January 2018

Identifiers

10.1111/VDE.12364

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/27647513

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51486830&oldid=1510073170"